Core Points - Cara Therapeutics, Inc. has announced a 1-for-3 reverse stock split of its outstanding shares of common stock [1] - The company's common stock will begin trading under the new name "Tvardi Therapeutics, Inc." and the new symbol "TVRD" following the merger with Tvard Therapeutics, Inc. [2] - The reverse stock split was approved by stockholders and will reduce the number of outstanding shares from approximately 4.6 million to approximately 1.5 million [3][4] Company Overview - Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing oral small molecule therapies targeting STAT3 for fibrosis-driven diseases [7] - Cara Therapeutics is a biopharmaceutical company that has developed an IV formulation of difelikefalin for treating moderate-to-severe pruritus associated with advanced kidney disease [8]

Core Viewpoint - China Pharma Holdings Inc. plans to implement a 1-for-10 reverse stock split effective April 15, 2025, with trading to begin on a split-adjusted basis on that day [1]. Group 1: Reverse Stock Split Details - The reverse stock split was authorized by the Company's Board of Directors on October 22, 2024, and adopted by stockholders during the Annual Meeting on December 22, 2024 [2]. - The fixed ratio of 1:10 for the reverse stock split was determined on March 26, 2025 [2]. - Upon the effectiveness of the reverse stock split, every 10 shares will convert into one share, with no fractional shares issued; any resulting fractional shares will be rounded up to the next whole number [3]. Group 2: Company Overview - China Pharma Holdings, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, and marketing products for high-incidence and high-mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases [4]. - The Company operates a cost-effective business model driven by market demand and has a nationwide distribution network across major cities and provinces in China [4]. - The Company's wholly-owned subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd., is located in Haikou City, Hainan Province [4].

Core Viewpoint - Antelope Enterprise Holdings Limited will implement a 1-for-40 reverse stock split of its Class A ordinary shares effective April 4, 2025, to comply with NASDAQ's minimum bid price requirement of $1.00 per share [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will consolidate every 40 issued and outstanding Ordinary Shares into one Ordinary Share, reducing the total number of shares from approximately 41,430,051 to about 1,035,752 [3]. - Shareholders entitled to fractional shares will receive one full share instead of a fractional share [3]. - All outstanding stock options, warrants, and other rights to purchase the Company's Ordinary Shares will be adjusted proportionately due to the reverse stock split [3]. Group 2: Compliance and Listing Requirements - The reverse stock split is aimed at regaining compliance with NASDAQ's requirement that the Company's common stock must have a closing bid price of $1.00 or more for at least ten consecutive trading days by April 30, 2025 [2]. - There is uncertainty regarding whether the Ordinary Shares will remain above the $1.00 minimum bid price after the reverse split, which is crucial for maintaining NASDAQ listing compliance [2]. Group 3: Company Overview - Antelope Enterprise holds a 51% ownership stake in Hainan Kylin Cloud Services Technology Co. Ltd, which operates a livestreaming e-commerce business in China, providing access to over 800,000 hosts and influencers [5].

Core Viewpoint - Ohmyhome Ltd. has announced a reverse stock split of its ordinary shares at a ratio of 1-for-10, aimed at complying with Nasdaq's minimum bid price requirement [1][4]. Group 1: Reverse Stock Split Details - The reverse stock split will reduce the total number of outstanding ordinary shares from approximately 24 million to about 2.4 million [2]. - The effective date for the reverse stock split is March 10, 2025, and the new par value of the shares will be adjusted to $0.01 per share [3]. - Outstanding warrants and options will be adjusted proportionately in accordance with the reverse stock split, with no fractional shares issued [5]. Group 2: Compliance and Corporate Actions - The reverse stock split is part of Ohmyhome's strategy to meet Nasdaq's requirement of maintaining a minimum bid price of at least $1.00 per share [4]. - The Company has amended its Memorandum of Association to proportionately reduce the number of authorized shares for issuance [3]. Group 3: Company Overview - Ohmyhome is a property technology platform in Singapore, providing end-to-end property solutions including brokerage, renovation, and property management services [7]. - Since its launch in 2016, Ohmyhome has transacted over 15,500 properties and manages approximately 9,300 units as of October 29, 2024 [7].

FORM S-1 As filed with the Securities and Exchange Commission on July 18, 2024. Registration Number 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCORPIUS HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 26-2844103 (I.R.S. Employer Identification No.) 627 Davis Drive, S ...

Table of Contents WASHINGTON, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Digital Brands Group, Inc. (Exact name of registrant as specified in its charter) As filed with the Securities and Exchange Commission on August 24, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) 1400 Lavaca Street Austin, TX 78701 (209) 651-0172 (Address and ...

As filed with the Securities and Exchange Commission on June 13, 2023 Registration Statement No. 333-271558 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 2 Burlington Woods Drive, Suite 100 Burlington, MA 01803 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BONE BIOLOGICS CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 42-1743430 (Primary Standard Ind ...

As filed with the Securities and Exchange Commission on June 8, 2023 Registration No. 333-269576 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GREENLANE HOLDINGS, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Delaware 5099 83-0806637 (I.R.S. Employer Identification Nu ...

As filed with the Securities and Exchange Commission on June 6, 2023 Registration Statement No. 333-271558 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BONE BIOLOGICS CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 42-1743430 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Ident ...

As filed with the Securities and Exchange Commission on April 4, 2023 Registration No. 333-269089 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No.1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GREENWAVE TECHNOLOGY SOLUTIONS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Identification Number) Delaware 7370 4 ...